Gene hunt: can DNA predict brain bleed risk?
NCT ID NCT04772963
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the genes of 300 people with brain or spinal cord arteriovenous malformations (AVMs) to see if certain mutations affect the risk of bleeding. Researchers will compare genetic information with medical outcomes to better understand why some AVMs cause serious problems. The goal is to improve prognosis and guide treatment decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTERIOVENOUS MALFORMATIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
HOPITAL FONDATION Adolphe de ROTHSCHILD
RECRUITINGParis, 75019, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Massive HHT registry aims to unlock secrets of rare bleeding disorder
- Brain AVM drug trial pulled before it began
- Could a transplant drug shrink dangerous blood vessel tangles?
- Massive study aims to predict brain surgery success
- New study tracks pregnancy dangers in rare vascular conditions
- New hope for rare blood vessel disorders: everolimus trial launches